Saturday, July 4, 2026

North Korea’s Nyongbyon Nuclear Facility Continues to Operate for 7th Nuclear Test

Satellite images and thermal infrared images of...

Discover the Premium 9-Pin Needle: Revolutionizing Aesthetic Treatments in China

Huons Meditech launches its Premium 9-Pin Needle in China, enhancing aesthetic treatments with innovative design and NMPA certification.

South Korean Warship Makes Waves in Balikatan Military Training

HD Hyundai Heavy Industries announced that the...

Tag: p53 Y220C mutation

North Korea Korea Kim Military AI South Korea market relations International

LG Chem’s FMC-220: A Breakthrough Cancer Drug Targeting the p53 Y220C Mutation

LG Chem secures exclusive rights to FMC-220, a cancer drug targeting the p53 Y220C mutation, aiming for Phase 1 trials.

Top News

Is North Korea Restructuring Its Foreign Affairs? Meet Chang Kom-chol, the...

Min Joo Yoo - March 26, 2026

Chang Kom-chol's new role as North Korea's First Vice Minister of Foreign Affairs signals a shift in inter-Korean diplomatic strategy.

How BTS is Making History: 82 Concerts Across 34 Cities in...

January 28, 2026

Robots, English, and AI—North Korea’s Schools Suddenly Sound Like Silicon Valley

September 15, 2025

A NEW BEGINNING: South Korea Gives North Korean Defectors A Second...

November 18, 2025

Why Kim Geun-sik Compares Party Conflicts to North Korea’s Purges: A...

March 4, 2026

How ARKO’s 2025 Sustainability Report Achieved Platinum Award: A Deep Dive...

March 11, 2026

How Celltrion Plans to Expand Its Biosimilar Portfolio to 41 Products...

January 14, 2026

Kolmar BNH Wins Global HACCP at Two Plants: Raising Food Safety...

January 14, 2026

- Our Sponsors Ad -

Follow us